Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Dec. 2, 1996

Frog peptides with antimicrobial activity available for licensing

Dec. 2, 1996

Antimicrobial peptide combinations available for licensing

Dec. 2, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

Antimicrobial ranalexin peptides available for licensing

Nov. 28, 1996

New antibacterial agents under study at Bayer

Nov. 28, 1996

FDA approves Amphotec

Nov. 27, 1996

Children's Hospital of Philadelphia offers antimicrobial peptides for licensing

Nov. 27, 1996

Cationic antimicrobial peptides available for licensing

Nov. 26, 1996

New treatment for S. pneumoniae infection available for licensing

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...